{"name": "Regulus Therapeutics",
 "permalink": "regulus-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/regulus-therapeutics",
 "homepage_url": "http://www.regulusrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@regulusrx.com",
 "phone_number": "888-734-8587",
 "description": "",
 "created_at": "Wed Jun 23 04:06:40 UTC 2010",
 "updated_at": "Thu Aug 16 02:56:08 UTC 2012",
 "overview": "\u003Cp\u003ERegulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs.\u003C/p\u003E\n\n\u003Cp\u003EThe discovery of microRNA in humans is one of the most exciting scientific breakthroughs in the last decade. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. More than 700 microRNAs have been identified in the human genome, and more than one-third of all human genes are believed to be regulated by microRNAs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0009/1448/91448v1-max-150x150.png"],
     [[203,
       45],
      "assets/images/resized/0009/1448/91448v1-max-250x250.png"],
     [[203,
       45],
      "assets/images/resized/0009/1448/91448v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Kleanthis",
      "last_name": "G. Xanthopoulos",
      "permalink": "kleanthis-g-xanthopoulos",
      "image": null}},
   {"is_past": false,
    "title": "CTO",
    "person":
     {"first_name": "Peter",
      "last_name": "S. Linsley",
      "permalink": "peter-s-linsley",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2010/10/regulus-therapeutics-receives-10m.html",
    "source_description": "Regulus Therapeutics Receives $10M Equity Investment from Sanofi-Aventis",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 28,
    "investments":
     [{"company":
        {"name": "Sanofi Aventis",
         "permalink": "sanofi-aventis-2",
         "image":
          {"available_sizes":
            [[[150,
               119],
              "assets/images/resized/0005/4534/54534v3-max-150x150.png"],
             [[150,
               119],
              "assets/images/resized/0005/4534/54534v3-max-250x250.png"],
             [[150,
               119],
              "assets/images/resized/0005/4534/54534v3-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1896 Rutherford Road",
    "address2": "",
    "zip_code": "92008",
    "city": "Carlsbad",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Regulus pairs with Sanofi in $750M microRNA pact",
    "stoned_year": 2010,
    "stoned_month": 6,
    "stoned_day": 22,
    "source_url": "http://www.fiercebiotech.com/story/regulus-pairs-sanofi-750m-microrna-pact/2010-06-22?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Regulus pairs with Sanofi in $750M microRNA pact",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Regulus Therapeutics",
      "permalink": "regulus-therapeutics"}},
   {"description": "AstraZeneca hands over $28M to team with Regulus on cardio pact",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 15,
    "source_url": "http://www.fiercebiotech.com/story/astrazeneca-hands-over-28m-team-regulus-cardio-pact/2012-08-15?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "AstraZeneca hands over $28M to team with Regulus on cardio pact",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Regulus Therapeutics",
      "permalink": "regulus-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}